Literature DB >> 18055091

Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells.

Lawrence H Lash1, David A Putt, Hongliang Cai.   

Abstract

We previously catalogued expression and activity of organic anion and cation, amino acid, and peptide transporters in primary cultures of human proximal tubular (hPT) cells to establish them as a cellular model to study drug transport in the human kidney [Lash, L.H., Putt, D.A., Cai, H., 2006. Membrane transport function in primary cultures of human proximal tubular cells. Toxicology 228, 200-218]. Here, we extend our analysis to drug metabolism enzymes. Expression of 11 cytochrome P450 (CYP) enzymes was determined with specific antibodies. CYP1B1, CYP3A4, and CYP4A11 were the only CYP enzymes readily detected in total cell extracts. These same CYP enzymes, as well as CYP3A5 and possibly CYP2D6, were detected in microsomes from confluent hPT cells, although expression levels varied among kidney samples. In agreement with Western blot data, only activity of CYP3A4/5 was detected among the enzyme activities measured. Expression of all three glutathione S-transferases (GSTs) known to be found in hPT cells, GSTA, GSTP, and GSTT, was readily detected. Variable expression of three sulfotransferases (SULTs), SULT1A3, SULT1E, and SULT2A1, and three UDP-glucuronosyltransferases (UGTs), UGT1A1, UGT1A6, and UGT2B7, was also detected. When examined over the course of cell growth to confluence, expression of all enzymes was generally maintained at readily measurable levels, although they were often lower than in fresh tissue. These results indicate that primary cultures of hPT cells possess significant capacity to metabolize many classes of drugs, and can be used as an effective model to study drug metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055091      PMCID: PMC2225475          DOI: 10.1016/j.tox.2007.10.022

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  21 in total

1.  Cellular energetics and glutathione status in NRK-52E cells: toxicological implications.

Authors:  Lawrence H Lash; David A Putt; Sarah E Hueni; Wei Cao; Feng Xu; Stephen J Kulidjian; Judith P Horwitz
Journal:  Biochem Pharmacol       Date:  2002-11-15       Impact factor: 5.858

2.  Roles of necrosis, Apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells.

Authors:  Lawrence H Lash; David A Putt; Sarah E Hueni; Renee J Krause; Adnan A Elfarra
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

3.  Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues.

Authors:  J A Campbell; A V Corrigall; A Guy; R E Kirsch
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

4.  Role of cytochrome P450 and glutathione S-transferase alpha in the metabolism and cytotoxicity of trichloroethylene in rat kidney.

Authors:  B S Cummings; J C Parker; L H Lash
Journal:  Biochem Pharmacol       Date:  2000-03-01       Impact factor: 5.858

5.  Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells.

Authors:  B S Cummings; L H Lash
Journal:  Toxicol Sci       Date:  2000-02       Impact factor: 4.849

6.  Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells.

Authors:  L H Lash; S E Hueni; D A Putt
Journal:  Toxicol Appl Pharmacol       Date:  2001-11-15       Impact factor: 4.219

7.  Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity.

Authors:  Renee J Krause; Lawrence H Lash; Adnan A Elfarra
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

8.  Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat.

Authors:  R A Lubet; R T Mayer; J W Cameron; R W Nims; M D Burke; T Wolff; F P Guengerich
Journal:  Arch Biochem Biophys       Date:  1985-04       Impact factor: 4.013

Review 9.  Polymorphism of cytochrome P-450 in humans.

Authors:  F P Guengerich
Journal:  Trends Pharmacol Sci       Date:  1989-03       Impact factor: 14.819

10.  Human cytochrome P450 enzyme selectivities in the oxidation of chlorinated benzenes.

Authors:  J J Bogaards; B van Ommen; C R Wolf; P J van Bladeren
Journal:  Toxicol Appl Pharmacol       Date:  1995-05       Impact factor: 4.219

View more
  18 in total

1.  Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin.

Authors:  Katherine L Gill; J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2012-01-24       Impact factor: 3.922

2.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

Review 3.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

4.  Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies.

Authors:  Xiaowan Zheng; Lei Diao; Sean Ekins; James E Polli
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 5.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  AAPS J       Date:  2016-06-30       Impact factor: 4.009

6.  Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.

Authors:  Magali Araujo; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

7.  A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro.

Authors:  Melanie Adler; Susanne Ramm; Marc Hafner; Jeremy L Muhlich; Esther Maria Gottwald; Elijah Weber; Alenka Jaklic; Amrendra Kumar Ajay; Daniel Svoboda; Scott Auerbach; Edward J Kelly; Jonathan Himmelfarb; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2015-08-10       Impact factor: 10.121

8.  Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.

Authors:  Gleb Martovetsky; James B Tee; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2013-09-13       Impact factor: 4.436

9.  Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data.

Authors:  Katherine L Gill; Michael Gertz; J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2013-01-09       Impact factor: 3.922

10.  3-D Human Renal Tubular Organoids Generated from Urine-Derived Stem Cells for Nephrotoxicity Screening.

Authors:  Haibin Guo; Nan Deng; Lei Dou; Huifen Ding; Tracy Criswell; Anthony Atala; Cristina M Furdui; Yuanyuan Zhang
Journal:  ACS Biomater Sci Eng       Date:  2020-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.